Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

VRXAVeraxa Biotech AG - Post de-SPAC

Nasdaq · CIK 0002079109
Filer category<br>Emerging growth company
Entity typeother
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts5

Identity from submissions API

NameVeraxa Biotech AG - Post de-SPAC
CIK0002079109
TickersVRXA, VRXAW
ExchangesNasdaq, Nasdaq
Entity typeother
Category<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationV8 Switzerland
Phone41443858450
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Veraxa Biotech Holding AG (2025-07-31T00:00:00.000Z → 2026-08-13T00:00:00.000Z)
Business address
TALACKER 35
ZURICH
8001
Switzerland
V8
Mailing address
TALACKER 35
ZURICH
8001
Switzerland
V8

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

57 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 6-K 6-K 0001829126-26-012674 001-43342 261574894 34 70569
2026-10-29 4 FORM 4 0001829126-26-011778 6379
2026-10-21 4 FORM 4 0001829126-26-011387 4897
2026-10-15 6-K 6-K 0001829126-26-011185 001-43342 261463171 34 164094
2026-09-14 3 FORM 3 0001829126-26-010085 3334
2026-09-04 424B3 424B3 0001829126-26-009754 333-297908 261360174 33 154195
2026-09-04 424B3 424B3 0001829126-26-009753 333-297907 261360172 33 152081
2026-09-04 6-K 6-K 0001829126-26-009752 001-43342 261360170 34 141646
2026-08-31 4 FORM 4 0001829126-26-009544 5344
2026-08-31 4 FORM 4 0001829126-26-009543 4938
2026-08-24 6-K 6-K 0001829126-26-009237 001-43342 261306343 34 67312
2026-08-20 3 FORM 3 0001829126-26-009154 3313
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001167557-26-000206 005-95754 261271527 34 10484
2026-08-10 424B5 424B5 0001829126-26-008548 333-297908 261259619 33 5034427
2026-08-10 424B5 424B5 0001829126-26-008547 333-297907 261259584 33 4951064
2026-08-06 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002591 333-297907 261256016 33 1787
2026-08-06 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002577 333-297908 261251215 33 1787
2026-08-05 F-1/A F-1/A 0001829126-26-008400 333-297907 261245004 33 431590 1 1
2026-08-05 F-1/A F-1/A 0001829126-26-008399 333-297908 261245002 33 495889 1 1
2026-07-31 F-1 F-1 0001829126-26-008247 333-297908 261229496 33 12605699 1 1
2026-07-31 F-1 F-1 0001829126-26-008246 333-297907 261229493 33 12513369 1 1
2026-07-31 6-K 6-K 0001829126-26-008238 001-43342 261228416 34 158142
2026-07-27 6-K 6-K 0001829126-26-007881 001-43342 261205738 34 186839
2026-07-27 6-K 6-K 0001829126-26-007854 001-43342 261202731 34 1376720
2026-06-18 6-K 6-K 0001829126-26-006695 001-43342 261104087 34 145461
2026-06-16 20-F 20-F 0001829126-26-006546 001-43342 261095069 34 7593589 1 1
2026-06-16 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0002134715-26-000001 005-95754 261094458 34 12845
2026-06-16 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0002134838-26-000001 005-95754 261094394 34 12504
2026-06-15 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0002134549-26-000001 005-95754 261090596 34 12771
2026-06-15 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0002134649-26-000001 005-95754 261090491 34 12588
2026-06-11 6-K 6-K 0001829126-26-006329 001-43342 261080908 34 163311
2026-06-10 CERT VRXA_8A_Cert_0002079109.pdf 0001354457-26-000557 001-43342 261079036 34 179760
2026-06-10 8-A12B/A 8-A12B/A 0001829126-26-006302 001-43342 261078863 34 21868
2026-06-10 3 PRIMARY DOCUMENT 0002128575-26-000001 3082
2026-06-10 3 PRIMARY DOCUMENT 0002123272-26-000001 3685
2026-06-09 3 PRIMARY DOCUMENT 0001438327-26-000003 3620
2026-06-09 3 PRIMARY DOCUMENT 0002129436-26-000001 4124
2026-06-09 3 PRIMARY DOCUMENT 0002123284-26-000001 3122
2026-06-09 3 PRIMARY DOCUMENT 0002123230-26-000001 3099
2026-06-09 3 PRIMARY DOCUMENT 0002128569-26-000001 3162
2026-06-09 8-A12B 8-A12B 0001829126-26-006236 001-43342 261076019 34 21059
2026-02-19 424B3 424B3 0001829126-26-001490 333-289108 26655690 33 12274395
2026-02-17 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000595 333-289108 26645174 33 3663
2026-02-13 CORRESP filename1.htm 0001829126-26-001328 9030
2026-02-13 F-4/A F-4/A 0001829126-26-001295 333-289108 26628189 33 10011522
2026-02-12 CORRESP filename1.htm 0001829126-26-001296 31193
2026-02-11 UPLOAD filename1.pdf 0000000000-26-001416 333-289108 44010
2026-02-03 F-4/A F-4/A 0001829126-26-000902 333-289108 26590157 33 9784380
2025-11-28 CORRESP filename1.htm 0001829126-25-009493 37859
2025-11-28 F-4/A F-4/A 0001829126-25-009492 333-289108 251532248 33 9587443
2025-11-20 UPLOAD filename1.pdf 0000000000-25-010891 333-289108 48975
2025-09-30 425 425 0001829126-25-007783 333-289108 251361563 34 175617
2025-09-29 F-4/A F-4/A 0001829126-25-007725 333-289108 251357015 33 9563832
2025-09-29 CORRESP filename1.htm 0001829126-25-007726 148814
2025-08-27 UPLOAD filename1.pdf 0000000000-25-009215 333-289108 84087
2025-07-31 F-4/A F-4/A 0001829126-25-005637 333-289108 251169638 33 8053392
2025-07-31 F-4 F-4 0001829126-25-005620 333-289108 251169034 33 8583453

Latest XBRL company facts

One latest value per concept from companyfacts (5 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
ffd NetFeeAmt NetFeeAmt USD 6,835.95 2026-07-30 F-1 2026-07-31 0001829126-26-008246
ffd TtlFeeAmt TtlFeeAmt USD 6,835.95 2026-07-30 F-1 2026-07-31 0001829126-26-008246
ffd TtlOfferingAmt TtlOfferingAmt USD 49.50M 2026-07-30 F-1 2026-07-31 0001829126-26-008246
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-07-30 F-1 2026-07-31 0001829126-26-008246
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-07-30 F-1 2026-07-31 0001829126-26-008246

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →